SUD 0.00% 4.2¢ suda pharmaceuticals ltd

Aytu BioScience Announces ZolpiMist Global Distribution Agreement with SUDA Pharmaceuticals, page-25

  1. 52 Posts.
    lightbulb Created with Sketch. 21
    What is interesting is that AYTU obviously have enough data from their own sales of Zolpimist to feel confident enough to buy out MAGNA. I think it is also a possibility they would be interested in acquiring other territories or indeed even a full buy out of Zolpimist to give them a global market. Very good news in my opinion.
 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.